<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02966392</url>
  </required_header>
  <id_info>
    <org_study_id>16HN</org_study_id>
    <nct_id>NCT02966392</nct_id>
  </id_info>
  <brief_title>Continuous Endotracheal Cuff Pressure Control to Prevent Ventilator Associated Respiratory Infections</brief_title>
  <acronym>VARI-prevent</acronym>
  <official_title>A Randomised Controlled Trial of Continuous Endotracheal Cuff Pressure Control for the Prevention of Ventilator Associated Respiratory Infections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oxford University Clinical Research Unit, Vietnam</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Trung Vuong Hospital, Ho Chi Minh City, Vietnam</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The National Hospital for Tropical Diseases, Ha Noi, Vietnam</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oxford University Clinical Research Unit, Vietnam</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine whether automated cuff pressure control results in a
      reduction in the proportion of patients developing ventilator associated respiratory
      infections during their stay in intensive care.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The proposed study is a randomized controlled trial of tracheal cuff pressure control using
      continuous control via an automated electronic device as compared with intermittent pressure
      control for the prevention of ventilator associated respiratory infection in ICU.

      The study will be conducted at multiple sites in Vietnam. Recruitment will be for 18 months
      at all centers. Patients experiencing any hospital acquired infection whilst at risk of
      Ventilator Associated Respiratory Infections will be evaluated in using a standardised
      investigation protocol to identify cases of VARI and other hospital acquired infections
      (HAI)s. Assessment of VARI will be based on published criteria and carried out by an endpoint
      review committee independent of patient care and blinded to the allocation of the patient.
      Antibiotic use data and duration of stay will be important secondary outcome measures.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ventilator Associated Respiratory Infection (VARI) - defined as Ventilator Associated Pneumonia (VAP) or Ventilator Associated Tracheobronchitis (VAT)</measure>
    <time_frame>From randomisation to ICU discharge/death/transfer or 90 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Microbiologically confirmed VARI defined as above plus bacterial growth of ≥105 cfu/ml (ETA) or equivalent semi-quantitative for both VAP and VAT</measure>
    <time_frame>From randomisation to ICU discharge/death/transfer or 90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical and microbiologically confirmed VAP (see above for definitions)</measure>
    <time_frame>From randomisation to ICU discharge/death/transfer or 90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intubated days receiving antibiotics</measure>
    <time_frame>From randomisation to ICU discharge/death/transfer or 90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of hospital acquired infection</measure>
    <time_frame>From randomisation to extubation/death/transfer/discharge/ from ICU or 90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total number of days ventilated/in ICU</measure>
    <time_frame>From randomisation to ICU discharge, death, transfer or 90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost of ICU stay</measure>
    <time_frame>From ICU admission to ICU discharge, death, transfer or 90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost of antibiotics in ICU stay</measure>
    <time_frame>From ICU admission to ICU discharge, death, transfer or 90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost of hospital stay</measure>
    <time_frame>From hospital admission to hospital discharge or 90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>28 day mortality</measure>
    <time_frame>From randomisation to 28 days after randomisation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>90 day mortality</measure>
    <time_frame>From randomisation to 90 days after randomisation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU mortality</measure>
    <time_frame>From randomisation to discharge from ICU or death/palliative discharge from it or 90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital mortality</measure>
    <time_frame>From randomisation to discharge from ICU or death/palliative discharge from it or 90 days</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Grade 3 &amp;4 adverse events relating to endotracheal cuff pressure</measure>
    <time_frame>From randomisation to 90 days</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Mechanical Ventilation Complication</condition>
  <condition>Tracheal Intubation Morbidity</condition>
  <condition>Ventilator-Associated Pneumonia</condition>
  <condition>Hospital Acquired Infection</condition>
  <arm_group>
    <arm_group_label>Continuous Pressure Control (CPC)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Continuous endotracheal cuff pressure control using Tracoe cuff pressure controller during their intubated stay on ICU.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Intermittent cuff pressure control through manual measurement performed 3 times per day (standard care)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tracoe cuff pressure controller</intervention_name>
    <description>Participant will be attached to the cuff pressure controller as soon as possible after enrolment. They will remain attached during their intubated stay. If reintubated during same admission they will continue in the intervention arm. If readmitted to ICU they will be managed according to standard care.</description>
    <arm_group_label>Continuous Pressure Control (CPC)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  About to be intubated or intubated for ≤ 24 hours (either oral or tracheostomy)

          -  For active treatment

        Exclusion Criteria:

          -  previously enrolled in this study

          -  previously intubated within 14 days

          -  suffering from known tracheomalacia, tracheal stenosis or stridor relating to tracheal
             injury
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Behzad Nadjm, MBChB MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oxford University Clinical Research Unit</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Behzad Nadjm, MBChB MD</last_name>
    <email>bnadjm@oucru.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Clinical Trials Unit Oxford University Clinical Research Unit</last_name>
    <email>CTU_Admin@oucru.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Hospital for Tropical Diseases</name>
      <address>
        <city>Hanoi</city>
        <country>Vietnam</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Clinical Trials Unit Oxford University Clinical Research Unit</last_name>
      <email>CTU_Admin@oucru.org</email>
    </contact>
    <investigator>
      <last_name>Kinh V Nguyen, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital for Tropical Diseases</name>
      <address>
        <city>Ho Chi Minh City</city>
        <country>Vietnam</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Unit Oxford University Clinical Research Unit</last_name>
      <email>CTU_Admin@oucru.org</email>
    </contact>
    <investigator>
      <last_name>Loan T Huynh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Trung Vuong Hospital</name>
      <address>
        <city>Ho Chi Minh City</city>
        <country>Vietnam</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Unit Oxford University Clinical Research Unit</last_name>
      <email>CTU-Admin@oucru.org</email>
    </contact>
    <investigator>
      <last_name>Chien T Le, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Binh T Nguyen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Vietnam</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 9, 2016</study_first_submitted>
  <study_first_submitted_qc>November 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 17, 2016</study_first_posted>
  <last_update_submitted>April 8, 2018</last_update_submitted>
  <last_update_submitted_qc>April 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cuff pressure</keyword>
  <keyword>Ventilator associated pneumonia</keyword>
  <keyword>Respiratory tract infections</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Pneumonia, Ventilator-Associated</mesh_term>
    <mesh_term>Respiratory Tract Infections</mesh_term>
    <mesh_term>Cross Infection</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>We hope to share IPD, however the framework to do so is not yet finalised with our collaborating institutions</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

